Neuroendocrine tumors can be benign or malignant; this section focuses on neuroendocrine cancer. These cancers are a varied group of diseases. Their names describe cells with features related to hormone production and nerve signaling. Neuroendocrine tumors can arise in different organs, including the digestive tract, pancreas, and lungs. Some release hormones that cause symptoms; others do not. The exact diagnosis matters more than the umbrella term. NCI: Neuroendocrine tumor
NET and NEC describe different diseases
In the digestive system, specialists distinguish well-differentiated neuroendocrine tumors (NETs) from poorly differentiated neuroendocrine carcinomas (NECs). Differentiation describes the cells' appearance and organization under a microscope.
Well-differentiated NETs have a range of behaviors. Some grow slowly; others grow more quickly. They can be low, intermediate, or high grade. Poorly differentiated NECs are high-grade cancers and generally behave more aggressively. A high-grade NET and a poorly differentiated NEC are separate diagnoses that can require different treatment approaches. NANETS: High-grade neuroendocrine neoplasm consensus recommendations
Symptoms do not tell the whole story
A gastrointestinal NET may cause no early symptoms. When symptoms develop, they can reflect the tumor's location or hormones it releases. Abdominal discomfort and diarrhea are examples, but many other conditions can cause these symptoms. Some hormone-producing gastrointestinal NETs cause carcinoid syndrome, which may include flushing and diarrhea. Symptoms alone cannot establish a diagnosis. NCI: Gastrointestinal neuroendocrine tumors
How the diagnosis is clarified
Evaluation may bring together the medical history, examination, laboratory tests, imaging, and a biopsy. A pathologist examines tissue to identify the disease. An abnormal blood test alone does not prove cancer, and a normal result does not rule it out. Ask your care team to explain how the different findings fit together. NCI: How cancer is diagnosed
Start with three separate questions
Where did the tumor begin? What does the pathology show about its type and grade? Where is it present in the body?
The last question concerns stage, which describes extent and spread. Stage and grade answer different questions. In particular, stage IV describes distant spread; it does not, by itself, establish that the tumor is high grade. NCI: Cancer staging
FOLLOW THE EVIDENCE
Sources & further reading
- NCI: Neuroendocrine tumor
- NANETS: High-grade neuroendocrine neoplasm consensus recommendations
- NCI: Gastrointestinal neuroendocrine tumors
- NCI: How cancer is diagnosed
- NCI: Cancer staging
Cited organizations have not endorsed this website. A linked source does not mean its authors reviewed this guide.
Something unclear or out of date?
Send a question or correctionInclude the page title and source, if available. Please do not send medical records or personal health details.